Premium
Calcium‐dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow‐derived mesenchymal stem cells
Author(s) -
Vigneault Patrick,
Naud Patrice,
Qi Xiaoyan,
Xiao Jiening,
Villeneuve Louis,
Davis Darryl R.,
Nattel Stanley
Publication year - 2018
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jp275388
Subject(s) - mesenchymal stem cell , microbiology and biotechnology , progenitor cell , bone marrow , stem cell , calcium in biology , calcium , potassium channel , intracellular , chemistry , biology , biophysics , immunology , organic chemistry
Key pointsEx vivo proliferated c‐Kit + endogenous cardiac progenitor cells (eCPCs) obtained from mouse and human cardiac tissues have been reported to express a wide range of functional ion channels. In contrast to previous reports in cultured c‐Kit + eCPCs, we found that ion currents were minimal in freshly isolated cells. However, inclusion of free Ca 2+ intracellularly revealed a prominent inwardly rectifying current identified as the intermediate conductance Ca 2+ ‐activated K + current (KCa3.1) Electrical function of both c‐Kit + eCPCs and bone marrow‐derived mesenchymal stem cells is critically governed by KCa3.1 calcium‐dependent potassium channels. Ca 2+ ‐induced increases in KCa3.1 conductance are necessary to optimize membrane potential during Ca 2+ entry. Membrane hyperpolarization due to KCa3.1 activation maintains the driving force for Ca 2+ entry that activates stem cell proliferation. Cardiac disease downregulates KCa3.1 channels in resident cardiac progenitor cells. Alterations in KCa3.1 may have pathophysiological and therapeutic significance in regenerative medicine.Abstract Endogenous c‐Kit + cardiac progenitor cells (eCPCs) and bone marrow (BM)‐derived mesenchymal stem cells (MSCs) are being developed for cardiac regenerative therapy, but a better understanding of their physiology is needed. Here, we addressed the unknown functional role of ion channels in freshly isolated eCPCs and expanded BM‐MSCs using patch‐clamp, microfluorometry and confocal microscopy. Isolated c‐Kit + eCPCs were purified from dog hearts by immunomagnetic selection. Ion currents were barely detectable in freshly isolated c‐Kit + eCPCs with buffering of intracellular calcium (Ca 2+ i ). Under conditions allowing free intracellular Ca 2+ , freshly isolated c‐Kit + eCPCs and ex vivo proliferated BM‐MSCs showed prominent voltage‐independent conductances that were sensitive to intermediate‐conductance K + ‐channel (KCa3.1 current, I KCa3.1 ) blockers and corresponding gene ( KCNN4 )‐expression knockdown. Depletion of Ca 2+ i induced membrane‐potential ( V mem ) depolarization, while store‐operated Ca 2+ entry (SOCE) hyperpolarized V mem in both cell types. The hyperpolarizing SOCE effect was substantially reduced by I KCa3.1 or SOCE blockade (TRAM‐34, 2‐APB), and I KCa3.1 blockade (TRAM‐34) or KCNN4 ‐knockdown decreased the Ca 2+ entry resulting from SOCE. I KCa3.1 suppression reduced c‐Kit + eCPC and BM‐MSC proliferation, while significantly altering the profile of cyclin expression. I KCa3.1 was reduced in c‐Kit + eCPCs isolated from dogs with congestive heart failure (CHF), along with corresponding KCNN4 mRNA. Under perforated‐patch conditions to maintain physiological [Ca 2+ ] i , c‐Kit + eCPCs from CHF dogs had less negative resting membrane potentials (−58 ± 7 mV) versus c‐Kit + eCPCs from control dogs (−73 ± 3 mV, P < 0.05), along with slower proliferation. Our study suggests that Ca 2+ ‐induced increases in I KCa3.1 are necessary to optimize membrane potential during the Ca 2+ entry that activates progenitor cell proliferation, and that alterations in KCa3.1 may have pathophysiological and therapeutic significance in regenerative medicine.